2011
DOI: 10.1002/pbc.23026
|View full text |Cite
|
Sign up to set email alerts
|

Systemic Mastocytosis in a Child With t(8;21) Acute Myeloid Leukemia

Abstract: Mastocytosis is primarily limited to the cutaneous variant in pediatric patients. Systemic mastocytosis (SM) has been associated with t(8;21) acute myeloid leukemia (AML) in adults. We provide the first report of a child with t(8;21) AML, diagnosed with asymptomatic SM following four cycles of chemotherapy. Unlike most adults with SM/AML, she was not found to have a c-KIT (D816V) mutation. SM persisted in the bone marrow after completion of chemotherapy, and her AML relapsed 9 months off-treatment. Although sh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(7 citation statements)
references
References 10 publications
0
7
0
Order By: Relevance
“…Although there are some cases reports of SMAHNMD in children, 7679 , this variant is more often seen in adults. ASM and MCL are rare variants with less favorable outcomes.…”
Section: Treatmentmentioning
confidence: 95%
“…Although there are some cases reports of SMAHNMD in children, 7679 , this variant is more often seen in adults. ASM and MCL are rare variants with less favorable outcomes.…”
Section: Treatmentmentioning
confidence: 95%
“…One pediatric patient with cutaneous mastocytosis at five years of age is reported to have evolved to mast cell leukemia at 23 years of age . There are reports of coincident acute myeloid leukemia in pediatric patients with SM but no prior reports of HLH as a complication of the disease …”
Section: Discussionmentioning
confidence: 99%
“…8 There are reports of coincident acute myeloid leukemia in pediatric patients with SM but no prior reports of HLH as a complication of the disease. 9,10 The etiology of SM remained elusive until Nagata et al showed mutations in the c-KIT gene, a proto-oncogene that encodes a receptor for the stem cell factor. 11,12 Their cohort of four patients with mastocytosis and myelodysplasia had a somatic mutation leading to an aspartic acid-to-valine substitution (Asp816Val) and activation of the tyrosine kinase.…”
Section: Discussionmentioning
confidence: 99%
“…A recent study in patients >15 years of age reported myeloproliferative disorders in the patient population of mainly adults with systemic mastocytosis (Cohen et al, 2014). There are, however, paediatric case reports of myeloproliferative diseases associated with systemic mastocytosis (n = 7) (Dror et al, 2000;Lee et al, 2007;Kanegane et al, 2009;Intzes et al, 2011;Mahadeo et al, 2011;Gadage et al, 2012), and one child with an apparent transition from cutaneous to systemic disease (Chantorn & Shwayder, 2012).…”
Section: Discussionmentioning
confidence: 99%